DORIPENEM: 239 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
239
Total FAERS Reports
78 (32.6%)
Deaths Reported
91
Hospitalizations
239
As Primary/Secondary Suspect
32
Life-Threatening
2
Disabilities
Oct 12, 2007
FDA Approved
Discontinued
Status
Active Ingredient: DORIPENEM MONOHYDRATE · FDA Application: 022106 ·
First Report: 20061120 · Latest Report: 20220224
What Are the Most Common DORIPENEM Side Effects?
#1 Most Reported
Pyrexia
28 reports (11.7%)
#2 Most Reported
Hepatic function abnormal
28 reports (11.7%)
#3 Most Reported
Diarrhoea
25 reports (10.5%)
All DORIPENEM Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hepatic function abnormal | 28 | 11.7% | 5 | 14 |
| Pyrexia | 28 | 11.7% | 4 | 16 |
| Diarrhoea | 25 | 10.5% | 7 | 15 |
| Sepsis | 20 | 8.4% | 8 | 5 |
| Drug ineffective | 17 | 7.1% | 7 | 13 |
| Liver disorder | 16 | 6.7% | 7 | 8 |
| Pneumonia | 15 | 6.3% | 9 | 9 |
| Drug resistance | 12 | 5.0% | 3 | 6 |
| Renal impairment | 12 | 5.0% | 6 | 8 |
| Febrile neutropenia | 10 | 4.2% | 1 | 5 |
| Multiple organ dysfunction syndrome | 10 | 4.2% | 9 | 8 |
| Off label use | 10 | 4.2% | 3 | 3 |
| Respiratory failure | 10 | 4.2% | 6 | 9 |
| Systemic candida | 10 | 4.2% | 3 | 3 |
| Toxic skin eruption | 10 | 4.2% | 0 | 5 |
| Bronchopulmonary aspergillosis | 9 | 3.8% | 9 | 5 |
| Candida infection | 9 | 3.8% | 1 | 2 |
| Rash | 9 | 3.8% | 3 | 8 |
| Renal failure | 9 | 3.8% | 8 | 4 |
| Drug eruption | 8 | 3.4% | 1 | 7 |
Who Reports DORIPENEM Side Effects? Age & Gender Data
Gender: 35.4% female, 64.6% male. Average age: 56.2 years. Most reports from: JP. View detailed demographics →
Is DORIPENEM Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2006 | 2 | 2 | 0 |
| 2007 | 8 | 4 | 3 |
| 2008 | 2 | 1 | 0 |
| 2009 | 2 | 2 | 0 |
| 2010 | 4 | 2 | 4 |
| 2011 | 2 | 2 | 0 |
| 2012 | 5 | 0 | 1 |
| 2013 | 19 | 4 | 10 |
| 2014 | 32 | 3 | 10 |
| 2015 | 25 | 7 | 11 |
| 2016 | 26 | 14 | 8 |
| 2017 | 10 | 4 | 6 |
| 2018 | 7 | 2 | 6 |
| 2019 | 3 | 1 | 2 |
| 2020 | 2 | 2 | 1 |
| 2021 | 1 | 0 | 0 |
| 2022 | 2 | 0 | 2 |
What Is DORIPENEM Used For?
| Indication | Reports |
|---|---|
| Pneumonia | 43 |
| Sepsis | 31 |
| Product used for unknown indication | 26 |
| Febrile neutropenia | 21 |
| Covid-19 | 9 |
| Antibiotic therapy | 6 |
| Bacterial infection | 6 |
| Septic shock | 6 |
| Pyrexia | 5 |
DORIPENEM vs Alternatives: Which Is Safer?
DORIPENEM vs DORNASE ALFA
DORIPENEM vs DORZOLAMIDE
DORIPENEM vs DORZOLAMIDE\TIMOLOL
DORIPENEM vs DOSTARLIMAB
DORIPENEM vs DOSTARLIMAB-GXLY
DORIPENEM vs DOTATATE GALLIUM GA-68
DORIPENEM vs DOTHIEPIN
DORIPENEM vs DOXAZOSIN
DORIPENEM vs DOXAZOSIN\DOXAZOSIN
DORIPENEM vs DOXEPIN
Official FDA Label for DORIPENEM
Official prescribing information from the FDA-approved drug label.